Diabetic Foot Care Resources for New York Families
An educational guide for New York families and caregivers exploring diabetic foot treatment options — Cuba's Heberprot-P intra-lesional therapy and intensive wound care program. Information to support informed decisions, in consultation with your healthcare provider.
Educational Resource — Not Medical Advice
The information on this page is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with your qualified healthcare provider before making decisions about treatment options.
We do not target, identify, or retarget individuals based on health conditions. This content is intended for families and caregivers seeking information about international treatment options, and is discoverable through organic search.
New York's diabetes burden is concentrated in underserved urban and rural communities, where advanced wound care options may be limited.
Getting to Cuba from New York
Traveling from New York to Cuba for diabetic foot treatment is straightforward. Our coordinators handle every step — from e-Visa processing to airport reception in Havana.
Departure Airports
New York (JFK) · Newark (EWR) · Miami connection
Flight Time
3 hours
e-Visa Included
We handle the application
Family Welcome
Accommodation for patient & family
The Cuban Diabetic Foot Program
Cuba has developed a comprehensive diabetic foot treatment program centered on Heberprot-P — a recombinant human epidermal growth factor (rh-EGF) administered by intra-lesional injection directly into the wound. This therapy is combined with intensive, multidisciplinary wound care. Our team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. Heberprot-P is not available in the United States.
- Heberprot-P intra-lesional rh-EGF therapy — a Cuban biotechnology innovation
- Intensive daily wound care by specialist teams
- Multidisciplinary team: endocrinologists, podiatrists, vascular surgeons, wound care nurses
- 4–8 week individualized program cycles with continuous monitoring
- Limb preservation focus — our team evaluates each patient individually
- Coordinated aftercare and handover to your US physician
Heberprot-P®
Cuban biotechnology
Recombinant human epidermal growth factor (rh-EGF) developed by Cuba's Center for Genetic Engineering and Biotechnology (CIGB), administered by intra-lesional injection directly into diabetic foot wounds to stimulate healing.
4–8 Week Cycles
Multidisciplinary Team
Diabetic Foot Care Resources
Explore our full range of educational diabetic foot care resources for US families and caregivers.
From First Inquiry to Safe Return Home
Contact Us
Share your medical information and wound history through our inquiry form.
Free Evaluation
Our wound care team reviews your US records and designs a personalized plan.
Travel Coordination
We assist with e-Visa, flights, and accommodation in Cuba.
Treatment
Receive intensive wound care with Heberprot-P therapy and continuous support.
Aftercare
Coordinated handover to your US physician with a monitoring plan.
Your Questions Answered
Submit Your Medical Records for a Diabetic Foot Evaluation
Our multidisciplinary team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. Share your medical records to receive a personalized assessment — often within 24–48 hours. No obligation, no travel required to get started.